TNF Inhibitors Often Ineffective, Affecting Certain Aspects of Life for AS Patients, Study Says
Treatment with tumor necrosis factor inhibitors (TNFi) is not effective for many patients with ankylosing spondylitis (AS), causing them to switch therapies and leading to lower quality of life and less work productivity, a large international study reports.